ReviewCancer medicine2017

Inhibition of CXCL12/CXCR4 axis as a potential targeted therapy of advanced gastric carcinoma.

Li-Jun Xue et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.